Protect yourself and loved ones with the

Free COVID-19 Vaccination
& Booster Programme

  • Open to Malaysians and non-Malaysians
  • For ages 12 and above
  • Primary vaccination available (1st and 2nd doses)
  • 1st and 2nd booster doses available
For more info, contact
NCSM at 014-7620739

Individual Vaccination

On-Site Group Vaccination

House-to-House Vaccination


Individual Vaccination

  • NCSM Kuala Lumpur
    66, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur
Day & Time
  • Mondays to Fridays: 9:00 am to 3:00 pm
  • Saturdays: 9:00 am to 12.30 pm

On-Site Group/Community Vaccination

  • Available within Peninsular Malaysia
  • Minimum 30 pax
  • Zero/No transportation charges

House-to-House Vaccination

  • Available within Peninsular Malaysia
  • Severely ill, bed-bound, with chronic conditions
  • Caregivers and/or members of the household
More Info →

Frequently Asked Questions (FAQ)

  • An additional dose given to those who has completed their primary 2 doses of COVID-19 vaccine.
  • Highly recommended.
  • The protection provided by the primary dose(s) of the vaccine decreases over time.
  • Booster dose helps people maintain the immunity against COVID-19 for a longer period of time.

  • Clinical guidelines on COVID-19 vaccination in Malaysia (4th edition)
  • COVID-19 Vaccine Booster Dose from Rhode Island Department of Health (

  • Yes. Dangerous new COVID-19 variants are forming.
  • It is safer to vaccinate and take booster shots to protect against COVID-19.
  • COVID-19 booster vaccine is highly recommended because:
    • Primary series of vaccine becomes less effective over time so individuals have risk for COVID-19 infection.
    • SARS-CoV-2 variants causes more severe infections and increase hospital admission rates.
    • Protects individuals from the severe infection symptoms (e.g. hospitalisation, ICU admissions,death).
    • Helps to regain prolonged immunity against COVID-19.

Booster vaccine recommendation based on age group
Age1st Booster2nd Booster
0- 4 years oldNot recommendedNot recommended
5-11 years oldRecommendedNot recommended
12-17 years oldRecommendedNot recommended
≥ 18 years oldRecommendedRecommended


  • The immunity formed after completion of vaccination decreases after 4–6 months after completing primary series of vaccines (proven by clinical trials done in Israel, United States.

  • WHO - Coronavirus disease (COVID-19) Vaccines
  • BMJ Elapsed time since BNT162b2 vaccine and risk of SARS COV2-infection (Published on 25 November 2021)
  • SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period
  • Six Month Safety and Efficacy of the Pfizer COVID-19

  • Yes, booster doses will ensure prolonged and stronger protection from the primary vaccination series.
  • Prevent severe illness, hospitalization, deaths and against new COVID-19 variants.
  • Clinical trials showed limited waning amongst symptomatic cases 10 or more weeks post booster dose, absolute effectiveness of booster vaccines (Pfizer) against hospitalization/death and reduced mortality rate.

  • Nature Medicine Journal - Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
  • The New England Journal of Medicine – Pfizer vaccine booster and mortality due of COVID-19

  • Approved by the National Pharmaceutical Regulatory Division (NPRA) for use in Malaysia
  • Safe
  • Effective
  • Crucial to protect vulnerable populations from severe symptoms from the COVID-19 infection/death
  • Reducing the infection rate of front-liners and elderly home caregivers

  • Clinical guidelines on COVID-19 vaccination in Malaysia (4th edition)

  • In Malaysia, only the Cominarty® (Pfizer) vaccine has been approved and licensed to be used as a booster vaccine.
  • Other vaccines can only be considered if Cominarty® (Pfizer) is contraindicated (unsuitable) for the individual.

  • Clinical guidelines on COVID-19 vaccination in Malaysia (4th edition)

  • Easily available.
  • Very effective in reducing serious symptoms/preventing death.
  • Bivalent vaccines requires approval of the conditional registration given by the Drug Control Authority.
  • Reports from China showed the subvariants from there has been detected in Malaysia.
  • A surge of COVID-19 infection is expected in the coming weeks.
  • All who have received their first booster dose > six months ago are highly recommended for second booster.
  • Not advisable to wait for the bivalent vaccine.

  • 12-17 years old with risk of severe medical conditions (e.g. chronic heart, lung, kidney, liver disease) after 4-6 months from their last vaccination.
  • Adults aged 18 and above who have completed vaccination at least 3-6 months ago.
  • All adults above 60 years old after 4-6 months from their first booster dose.
  • Priority is for the following populations:
    • High risk individuals with pre-existing medical conditions
    • Senior citizens
    • Frontline workers (health and non-health personnels)
    • Residents and staff in long-term health care centers such as elderly care centres
    • Pregnant or breastfeeding women
    • Individuals that need to travel abroad


  • Vaccination should be deferred until the person has recovered from the acute illness (if symptomatic) and has met criteria to discontinue isolation.


  • Yes, it is highly recommended.
  • Statistics from CDC shows people who had COVID-19 and unvaccinated are likely to get the infection.
  • Booster dose provides an additional protection against COVID-19 after one’s recovery from the infection.


  • Yes. Very much likely as the booster dose is not 100% effective in COVID-19 prevention.
  • COVID-19 infections post booster dose are less severe.


  • Yes. vaccines are not 100% effective at preventing COVID-19 infection, even in those who are fully vaccinated.
  • It takes 1-2 weeks after booster vaccine for it to become fully effective.
  • Research shows people who have taken the vaccine and gotten COVID-19 infection or vice versa has a better level of protection against COVID-19.


  • Yes. The COVID-19 vaccine is safe and effective during pregnancy.
  • Those who are pregnant have a higher risk of developing severe COVID-19 illness.
  • If infected during pregnancy, it may complicate the pregnancy and harm the mother and the unborn child.
  • No safety concerns for babies born to women who were vaccinated against COVID-19 during pregnancy.
  • DATA from The Ministry of Health Malaysia's Guidelines on COVID-19 vaccination:
    • Pregnant women can be vaccinated between 14-33 weeks of gestation, but to be recommended after doctor’s consultation.
    • Priority for pregnant women who are frontliners, or with comorbidities such as diabetes or obesity (high-risk).
    • If a women confirms pregnancy after first dose, she is recommended to defer the second dose until after 14 weeks of pregnancy.

  • Ministry of Health Malaysia's Guidelines on COVID-19 vaccination (page: 69)

  • Recommendations extracted from the Malaysia's Guidelines on COVID-19 vaccination from the MOH:
    • For moderately to severely immunocompromised individuals: minimal interval between the primary series of vaccination and the additional dose should be 28 days.
    • Booster dose for an elderly individual residing in aged care facilities: minimal interval between the 1- or 2- dose primary series and the booster dose should be 6 months.

  • Ministry of Health Malaysia's Guidelines on COVID-19 vaccination (page: 69)

  • Not necessarily. Vaccine efficacy as below:
  • 1st Dose2nd DoseBoosterStudy Result
    PFIZERPFIZERPFIZER62% reduction in infection risk
    AZAZPFIZER60% reduction in infection risk
    SINOVACSINOVACPFIZER95% reduction in infection risk
    SINOVACSINOVACAZ94% reduction in infection risk
    SINOVACSINOVACSINOVAC75% reduction in infection risk
  • Interim data from a clinical trial conducted by The University of Oxford supports flexibility in the mixing of vaccine; specifically Oxford/AstraZeneca and Pfizer-BioNTech, but does not apply to pregnant women as this population was not included in the study.

  • Clinical guidelines on COVID-19 vaccination in Malaysia (4th edition)
  • Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine (

  • Yes
  • The components (formulation) of COVID-19 boosters are the same as those of the current COVID-19 vaccines.

  • The dosage for one Pfizer-BioNTech COVID-19 booster dose is 0.3ml.

Additional dose:

  • For those who did not respond well to primary vaccination series (immunocompromised).
  • Given at least 28 days after completing the primary vaccination series.

Booster dose:
  • Given to those who had an adequate initial response.
  • Immunity may have waned over time (waning immunity).
  • Given 6 months after completing the primary vaccination series.

  • Common side effects :
    • Pain
    • Redness
    • Swelling at the injection site
    • Tiredness
    • Headache
    • Muscle pain
    • Chills
    • Fever
    • Nausea
  • On a positive note, these symptoms will usually get better after a few days.
  • Severe side effects can occur but mostly rare. Four examples of such:
    • Anaphylaxis: Severe allergic reaction - hives, respiratory problems, low blood pressure, or significant tongue or lip swelling.
    • Thrombosis with thrombocytopenia syndrome (TTS): A condition that interferes with blood clotting or forms blood clots.
    • Myocarditis and pericarditis: Inflammation of the heart muscle is known as myocarditis, while inflammation of the heart's outer lining is known as pericarditis.
    • Guillain-Barre Syndrome (GBS): An uncommon condition where the immune system of the body destroys nerve cells, leading to muscular weakness and occasionally paralysis.
    • Deaths: Rare

Source :

  • No. The absence of side effects after vaccination does not mean the vaccine is not working.
  • If one experiences side effects from the booster dose, it is the individual’s immune response to the vaccine.
  • Different individuals’ immune systems react in different ways due to different contributing factors including age, health, environment, nutrition, and gender.

Source :
  • Clinical guidelines on COVID-19 vaccination in Malaysia (4th edition)

  • Yes.
  • A COVID-19 booster is not compulsory for being fully vaccinated
  • Being fully vaccinated also does not guarantee the optimum level of protection.
  • Individuals are best protected when they receive their primary COVID-19 vaccination series and booster shots on time.
  • The type and brand of vaccines; and definition of fully vaccinated is subject to change according to recommendations from MOH and will be updated from time to time.

Fully Vaccinated Status
Vaccine TypeComplete Primary DoseNumber of Doses Required According to Vaccination StatusEffective Period of Vaccination Status After Last Injection
Fully Vaccinated (based on age)
18 - 60 years old60 years old & above
  • CoronaVac (Sinovac)
  • Covilo (Sinopharm)
2 doses3 doses3 doses

Primary dose injection:
14 days

Booster dose injection:
immediate after

  • Comirnaty (Pfizer-BioNTech)
  • COVID-19 AstraZeneca
  • (Oxford-AstraZeneca)
  • Spikevax (Moderna)
2 doses2 doses3 doses
  • COVID-19 Janssen (Johnson & Johnson
  • Convidecia (CanSino)
1 dose1 dose2 doses
  • Other vaccines
According to authorities of manufaturing countries approval

Source :

  • Yes.
  • An employer may require that their workers to get booster shot, my also make it mandatory.
  • Statistics reported by the Ministry of Health (MOH) showed 2839 workplace COVID-19 clusters involving 282,729 cases up till 12 September 2021.
  • COVID-19 booster dose is not mandatory but is highly recommended for the working population.

Source :

  • Yes.
  • The COVID-19 vaccines are not 100% effective at preventing COVID-19 and one can still spread the virus.
  • The safest way forward is to still adhere to the following preventive measures to stop the spread of the virus:
    • Maintain physical distancing (1 to 2 metres apart).
    • Wear protective mask, especially in crowded, closed and poorly ventilated places.
    • Wash your hands often with water and soap or clean it with 60% - 70% alcohol-based gel, foam, or liquid sanitiser.
    • Cough or sneeze into bent elbow.
    • Avoid crowds and poorly ventilated space.